SCHEMBL6646169

SCHEMBL6646169

Cc1c(N)nc2c(nc(N)c3cncn32)c1C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4042248 0.78 PRMT5 (0.33) LCK
SCHEMBL4046022 0.70 NOS1 (0.32)
SCHEMBL31325823 0.65 SRC (0.36) LCK
SCHEMBL8335810 0.65 LCK (0.34) LCK
SCHEMBL6645541 0.64 PDE10A (0.49) LCK
SCHEMBL31060458 0.64 LCK (0.40) LCK
SCHEMBL7987372 0.63 LCK (0.48) LCK
SCHEMBL31040798 0.62 LCK (0.37) LCK
SCHEMBL23459666 0.62 GAA (0.32)
SCHEMBL6645234 0.62 HRH4 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1066286-A4 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2004-02-11 EP claimed
EP-1066286-A1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2001-01-10 EP claimed
WO-1999045009-A1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-09-10 WO claimed